Advancing the Care of Children with Cerebrovascular Disease
Pediatric cerebrovascular disease is a significant cause of global morbidity and mortality among children.
Clinical Scorecard: Advancing the Care of Children with Cerebrovascular Disease
At a Glance
Category Detail
Condition Pediatric cerebrovascular disease Key Mechanisms Ischemic and hemorrhagic strokes due to various causes including arteriopathy and community-acquired bacterial meningitis. Target Population Children with cerebrovascular disease, including those with sickle cell disease and arteriopathy. Care Setting Pediatric neurology and neurovascular care settings.
Key Highlights
Endovascular thrombectomy improves neurological outcomes in children with acute intracranial large vessel occlusions. Focal cerebral arteriopathy is a leading cause of childhood ischemic stroke. Community-acquired bacterial meningitis can lead to ischemic stroke in 25-30% of cases. Sickle cell disease significantly increases the risk of childhood stroke. Transcranial Doppler screening and exchange transfusion can reduce stroke risk in children with sickle cell disease. Guideline-Based Recommendations
Diagnosis
Utilize imaging techniques such as digital subtraction angiography for assessment of cerebrovascular conditions. Management
Consider endovascular thrombectomy for children with acute intracranial large vessel occlusions. Monitoring & Follow-up
Implement transcranial Doppler screening for children with sickle cell disease. Risks
Monitor for stroke risk in children with sickle cell disease, especially between ages 2 and 5. Patient & Prescribing Data
Children with cerebrovascular disease, particularly those with sickle cell disease and arteriopathy.
Hematopoietic stem-cell transplant may provide benefits beyond hematological correction in sickle cell disease.
Clinical Best Practices
Develop collaborative multicenter protocols for pediatric cerebrovascular disease management. Utilize novel catheter-directed treatments for infectious arteritis in children. References
